A detailed history of Brevan Howard Capital Management LP transactions in Macrogenics Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 41,706 shares of MGNX stock, worth $134,710. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,706
Previous 21,522 93.78%
Holding current value
$134,710
Previous $91,000 50.55%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $5.55 $60,552 - $112,021
20,184 Added 93.78%
41,706 $137,000
Q2 2024

Aug 14, 2024

BUY
$3.31 - $18.51 $71,237 - $398,372
21,522 New
21,522 $91,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $199M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.